We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sysco
SYY
$40.9B
| $50.6M | 0.12% |
592,124
-28,200
| -5% | -$2.28M |
|
|
MRSH
202
Marsh
MRSH
$90.8B
| $50.3M | 0.12% |
451,079
-67,900
| -13% | -$7.09M |
|
203
Motorola Solutions
MSI
$72.6B
| $50.2M | 0.12% |
311,676
-14,500
| -4% | -$2.39M |
|
204
Aon
AON
$77.2B
| $49.6M | 0.12% |
238,063
-53,000
| -18% | -$10.5M |
|
205
Honeywell
HON
$77.7B
| $49.5M | 0.12% |
296,683
-502,264
| -63% | -$82.1M |
|
206
Ross Stores
ROST
$80.7B
| $49.2M | 0.12% |
422,939
-21,936
| -5% | -$2.47M |
|
|
BHVN
207
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $49M | 0.12% |
900,000
-675,000
| -43% | -$33.4M |
|
208
Phillips 66
PSX
$84.8B
| $48.5M | 0.12% |
435,601
+90,400
| +26% | +$10.2M |
|
|
FSR
209
DELISTED
Fisker Inc.
FSR
| $48.3M | 0.12% |
4,752,000
| – | – |
|
210
Voya Financial
VOYA
$9.02B
| $48.1M | 0.12% |
789,000
-245,000
| -24% | -$13.8M |
|
211
Corteva
CTVA
$53.8B
| $47.8M | 0.12% |
1,616,156
+760,936
| +89% | +$20.1M |
|
212
Marriott International
MAR
$99B
| $47.8M | 0.12% |
315,325
-19,300
| -6% | -$2.59M |
|
213
State Street
STT
$50.7B
| $47.7M | 0.12% |
602,900
+49,900
| +9% | +$3.51M |
|
214
MetLife
MET
$62.2B
| $47.4M | 0.12% |
930,076
-78,200
| -8% | -$3.77M |
|
215
nVent Electric
NVT
$25.5B
| $47.1M | 0.12% |
1,842,004
-1,059,925
| -37% | -$24.6M |
|
216
Autodesk
ADSK
$49.5B
| $46.9M | 0.12% |
255,689
+16,300
| +7% | +$2.64M |
|
217
Jabil
JBL
$33B
| $46.7M | 0.11% |
1,129,547
+76,947
| +7% | +$2.95M |
|
218
KLA
KLAC
$245B
| $46.6M | 0.11% |
2,615,140
-1,122,000
| -30% | -$18.8M |
|
219
Mettler-Toledo International
MTD
$28.4B
| $46.4M | 0.11% |
58,510
+35,700
| +157% | +$25.8M |
|
220
East-West Bancorp
EWBC
$17.9B
| $46.4M | 0.11% |
952,346
+103,850
| +12% | +$4.68M |
|
|
NVO
221
Novo Nordisk
NVO
$207B
| $46.3M | 0.11% |
1,600,000
-600,000
| -27% | -$16.6M |
|
222
Atmos Energy
ATO
$29B
| $46.1M | 0.11% |
411,776
+269,953
| +190% | +$29.6M |
|
|
DISCK
223
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $45.8M | 0.11% |
1,503,206
+1,066,699
| +244% | +$29.9M |
|
224
Nutrien
NTR
$33.5B
| $45.5M | 0.11% |
950,000
+550,000
| +138% | +$26.6M |
|
225
ProQR Therapeutics
PRQR
$246M
| $45.3M | 0.11% |
4,571,319
+835,812
| +22% | +$6.51M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.